Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2015-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this survey is to examine the safety and efficacy of long-term use of
alogliptin/pioglitazone(Liovel) combination tablets in patients with type 2 diabetes mellitus
determined as warranting combination therapy with alogliptin benzoate and pioglitazone
hydrochloride